M. Rohman

发表

High-Throughput Screening Using Mass Spectrometry within Drug Discovery.

J. Wingfield, M. Rohman, 2016, Methods in molecular biology.

Design of Selective sPLA2-X Inhibitor (-)-2-{2-[Carbamoyl-6-(trifluoromethoxy)-1H-indol-1-yl]pyridine-2-yl}propanoic Acid.

Tomas Åkerud, N. Selmi, E. Hurt-Camejo, 2018, ACS medicinal chemistry letters.

A serendipitously identified novel small molecule procoagulant compound giving rise to a high-throughput screening assay based on human plasma.

J. Ulander, O. Fjellström, J. Deinum, 2013, Thrombosis research.

Acoustic Mist Ionization Platform for Direct and Contactless Ultrahigh-Throughput Mass Spectrometry Analysis of Liquid Samples.

David C Murray, M. Morris, P. Barran, 2019, Analytical chemistry.

Inhibition of AMP deaminase activity does not improve glucose control in rodent models of insulin resistance or diabetes.

Mikael Bjursell, N. Selmi, T. Drmota, 2014, Chemistry & biology.

Discovery of the Oral Leukotriene-C4 Synthetase Inhibitor (1S,2S)-2-({5-[(5-Chloro-2,4-difluorophenyl)(2-fluoro-2-methylpropyl)amino]-3-methoxypyrazin-2-yl}carbonyl)cyclopropanecarboxylic acid (AZD9898) as a New Treatment for Asthma.

L. Swedin, U. Andersson, C. Tyrchan, 2019, Journal of medicinal chemistry.

Discovery of a Series of Indole-2 Carboxamides as Selective Secreted Phospholipase A2 Type X (sPLA2-X) Inhibitors.

Tomas Åkerud, N. Selmi, K. Hallberg, 2018, ACS Medicinal Chemistry Letters.

Discovery of a novel pyrazole series of group X secreted phospholipase A2 inhibitor (sPLA2X) via fragment based virtual screening.

Tomas Åkerud, K. Hallberg, Hongming Chen, 2014, Bioorganic & medicinal chemistry letters.

Fragment Screening of Soluble Epoxide Hydrolase for Lead Generation—Structure‐Based Hit Evaluation and Chemistry Exploration

Yafeng Xue, T. Olsson, S. Bäckström, 2016, ChemMedChem.

High-Quality Cost-Effective Compound Management Support for HTS

Maximiliano Zaragoza-Sundqvist, Hans Eriksson, Mattias Rohman, 2009, Journal of biomolecular screening.